SEC Form 4 · accession 0001127602-16-043516
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 12:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2016 | S | 500 | $70.98 | D | 394,834 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.00 | D | 394,734 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.01 | D | 394,634 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.02 | D | 394,534 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.035 | D | 394,434 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.07 | D | 394,234 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.075 | D | 394,134 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.09 | D | 394,034 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.14 | D | 393,934 | D | |
| Common Stock | Feb 24, 2016 | S | 300 | $71.18 | D | 393,634 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.20 | D | 393,434 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.21 | D | 393,234 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.25 | D | 393,034 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.26 | D | 392,934 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.49 | D | 392,734 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.495 | D | 392,634 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.50 | D | 392,534 | D | |
| Common Stock | Feb 24, 2016 | S | 400 | $71.52 | D | 392,134 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.535 | D | 391,934 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.545 | D | 391,834 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.56 | D | 391,634 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.57 | D | 391,534 | D | |
| Common Stock | Feb 24, 2016 | S | 300 | $71.59 | D | 391,234 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.60 | D | 391,134 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.635 | D | 391,034 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.645 | D | 390,834 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.